Supplementary Figure S2 shows the duration of treatment including response and tumor type (the safety analysis set)
No takes yet. Share an insight, caveat, or question.
Meric‐Bernstam et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: